LONDON, Nov 12 (Reuters) - London-listed drugmaker AstraZeneca (AZN.L), opens new tab said its plan to invest 450 million ...

In closing its therapeutics division and laying off 200 people, 23andMe ended an audacious bet it made nearly a decade ago — ...

Neurogene shares tumbled 35% last night after it disclosed that a pediatric patient with Rett syndrome experienced a severe ...

Nov 12 (Reuters) - Novavax (NVAX.O), opens new tab cut its annual revenue forecast on Tuesday, citing lower-than-expected ...

Reactogenicity is comparable for simultaneous and sequential administration of mRNA COVID-19 and influenza vaccines.

The other group at the highest risk when it comes to RSV is children under age five, and specifically infants—especially ...

More than one in two Irish parents say their child missed schools days in the past year due to flu or flu-like symptoms with ...

Investing.com - Moderna (NASDAQ:MRNA) has reported a shallower-than-anticipated loss in the third quarter and announced changes at its leadership team, as the drugmaker looks to address issues ...

A pioneering DNA test is being rolled out on the NHS as experts say there is a one in four chance of another pandemic on the scale of Covid-19 in the next decade ...

Some provinces have begun rolling out a vaccination program for infants with newly authorized products. The situation is much ...

Rwanda has been stepping up measures to combat Rift Valley Fever (RVF) following the country's second outbreak in two years, ...